Explorative data analysis of MCL reveals gene expression networks implicated in survival and prognosis supported by explorative CGH analysis

被引：38
作者：
Blenk S. [1 ]
Engelmann J.C. [1 ]
Pinkert S. [1 ]
Weniger M. [1 ]
Schultz J. [1 ]
Rosenwald A. [2 ]
Müller-Hermelink H.K. [2 ]
Müller T. [1 ]
Dandekar T. [1 ]
机构：
[1] Department of Bioinformatics, University of Würzburg, Biozentrum, D-97074 Würzburg, Am Hubland
[2] Institute for Pathology, University of Würzburg, D-97080 Würzburg
来源：
BMC Cancer | / 8卷 / 1期
关键词：
Proliferate Cell Nuclear Antigen; Comparative Genomic Hybridization; Mantle Cell Lymphoma; Proliferation Signature; Gene Predictor;
D O I：
10.1186/1471-2407-8-106
中图分类号：
学科分类号：
摘要：
Background: Mantle cell lymphoma (MCL) is an incurable B cell lymphoma and accounts for 6% of all non-Hodgkin's lymphomas. On the genetic level, MCL is characterized by the hallmark translocation t(11;14) that is present in most cases with few exceptions. Both gene expression and comparative genomic hybridization (CGH) data vary considerably between patients with implications for their prognosis. Methods: We compare patients over and below the median of survival. Exploratory principal component analysis of gene expression data showed that the second principal component correlates well with patient survival. Explorative analysis of CGH data shows the same correlation. Results: On chromosome 7 and 9 specific genes and bands are delineated which improve prognosis prediction independent of the previously described proliferation signature. We identify a compact survival predictor of seven genes for MCL patients. After extensive re-annotation using GEPAT, we established protein networks correlating with prognosis. Well known genes (CDC2, CCND1) and further proliferation markers (WEE1, CDC25, aurora kinases, BUB1, PCNA, E2F1) form a tight interaction network, but also non-proliferative genes (SOCS1, TUBA1B CEBPB) are shown to be associated with prognosis. Furthermore we show that aggressive MCL implicates a gene network shift to higher expressed genes in late cell cycle states and refine the set of non-proliferative genes implicated with bad prognosis in MCL. Conclusion: The results from explorative data analysis of gene expression and CGH data are complementary to each other. Including further tests such as Wilcoxon rank test we point both to proliferative and non-proliferative gene networks implicated in inferior prognosis of MCL and identify suitable markers both in gene expression and CGH data. © 2008 Blenk et al; licensee BioMed Central Ltd.
引用
收藏
相关论文
共 68 条
  • [1] Bogner C., Peschel C., Decker T., Targeting the proteasome in mantle cell lymphoma: A promising therapeutic approach, Leuk Lymphoma, 47, pp. 195-205, (2006)
  • [2] Argatoff L.H., Connors J.M., Klasa R.J., Horsman D.E., Gascoyne R.D., Mantle cell lymphoma: A clinicopathologic study of 80 cases, Blood, 89, pp. 2067-2078, (1997)
  • [3] Bosch F., Lopez-Guillermo A., Campo E., Ribera J.M., Conde E., Piris M.A., Vallespi T., Woessner S., Montserrat E., Mantle cell lymphoma: Presenting features, response to therapy, and prognostic factors, Cancer, 82, pp. 567-575, (1998)
  • [4] Raty R., Franssila K., Joensuu H., Teerenhovi L., Elonen E., Ki-67 expression level, histological subtype, and the International Prognostic Index as outcome predictors in mantle cell lymphoma, Eur J Haematol, 69, pp. 11-20, (2002)
  • [5] Velders G.A., Kluin-Nelemans J.C., De Boer C.J., Hermans J., Noordijk E.M., Schuuring E., Kramer M.H., Van Deijk W.A., Rahder J.B., Kluin P.M., Van Krieken J.H., Mantle-cell lymphoma: A population-based clinical study, J Clin Oncol, 14, pp. 1269-1274, (1996)
  • [6] Rosenwald A., Wright G., Wiestner A., Chan W.C., Connors J.M., Campo E., Gascoyne R.D., Grogan T.M., Muller-Hermelink H.K., Smeland E.B., Chiorazzi M., Giltnane J.M., Hurt E.M., Zhao H., Averett L., Henrickson S., Yang L., Powell J., Wilson W.H., Jaffe E.S., Simon R., Klausner R.D., Montserrat E., Bosch F., Greiner T.C., Weisenburger D.D., Sanger W.G., Dave B.J., Lynch J.C., Vose J., Armitage J.O., Fisher R.I., Miller T.P., LeBlanc M., Ott G., Kvaloy S., Holte H., Delabie J., Staudt L.M., The p
  • [7] Alizadeh A., Eisen M., Davis R.E., Ma C., Sabet H., Tran T., Powell J.I., Yang L., Marti G.E., Moore D.T., Hudson Jr. J.R., Chan W.C., Greiner T., Weisenburger D., Armitage J.O., Lossos I., Levy R., Botstein D., Brown P.O., Staudt L.M., The lymphochip: A specialized cDNA microarray for the genomic-scale analysis of gene expression in normal and malignant lymphocytes, Cold Spring Harb Symp Quant Biol, 64, pp. 71-78, (1999)
  • [8] Weniger M., Engelmann J.C., Schultz J., Genome Expression Pathway Analysis Tool-analysis and visualization of microarray gene expression data under genomic, proteomic and metabolic context, BMC Bioinformatics, 8, (2007)
  • [9] Gentleman R., Carey V., Bates M., Bolstad B., Dettling M., Dudoit S., Ellis B., Gautier L., Ge Y., Gentry J., Hornik K., Hothorn T., Huber W., Iacus S., Irizarry R., Leisch F., Li C., Maechler M., Rossini A.J., Sawitzki G., Smith C., Smyth G., Tierney L., Yang J.Y.H., Zhang J., Bioconductor: Open software development for computational biology and bioinformatics, Genome Biology, 5, (2004)
  • [10] A Language and Environment for Statistical Computing, (2007)
1234567